{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:21:14Z","timestamp":1787631674379,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI093269"],"award-info":[{"award-number":["R37 AI093269"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI058736"],"award-info":[{"award-number":["R37 AI058736"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Global Health Trials Scheme of the UK Department of Health and Social Care"},{"DOI":"10.13039\/100016270","name":"Global Challenges Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council, and Wellcome Trust"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["MR\/M007375\/1"],"award-info":[{"award-number":["MR\/M007375\/1"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Providence\/Boston Center for AIDS Research","award":["P30 AI042853"],"award-info":[{"award-number":["P30 AI042853"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI111276"],"award-info":[{"award-number":["U19 AI111276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["098316"],"award-info":[{"award-number":["098316"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation","award":["64787"],"award-info":[{"award-number":["64787"]}]},{"name":"NRF incentive funding","award":["UID: 85858"],"award-info":[{"award-number":["UID: 85858"]}]},{"DOI":"10.13039\/100009041","name":"National Department of Health","doi-asserted-by":"publisher","award":["TB\/HIV\/AIDS-01-2014"],"award-info":[{"award-number":["TB\/HIV\/AIDS-01-2014"]}],"id":[{"id":"10.13039\/100009041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A novel urine lipoarabinomannan assay (FujiLAM) has higher sensitivity and higher cost than the first-generation AlereLAM assay. We evaluated the cost-effectiveness of FujiLAM for tuberculosis testing among hospitalized people with human immunodeficiency virus (HIV), irrespective of symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used a microsimulation model to project clinical and economic outcomes of 3 testing strategies: (1) sputum Xpert MTB\/RIF (Xpert), (2) sputum Xpert plus urine AlereLAM (Xpert+AlereLAM), (3) sputum Xpert plus urine FujiLAM (Xpert+FujiLAM). The modeled cohort matched that of a 2-country clinical trial. We applied diagnostic yields from a retrospective study (yields for Xpert\/Xpert+AlereLAM\/Xpert+FujiLAM among those with CD4 &amp;lt;200 cells\/\u00b5L: 33%\/62%\/70%; among those with CD4 \u2265200 cells\/\u00b5L: 33%\/35%\/47%). Costs of Xpert\/AlereLAM\/FujiLAM were US$15\/3\/6 (South Africa) and $25\/3\/6 (Malawi). Xpert+FujiLAM was considered cost-effective if its incremental cost-effectiveness ratio (US$\/year-of-life saved) was &amp;lt;$940 (South Africa) and &amp;lt;$750 (Malawi). We varied key parameters in sensitivity analysis and performed a budget impact analysis of implementing FujiLAM countrywide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with Xpert+AlereLAM, Xpert+FujiLAM increased life expectancy by 0.2 years for those tested in South Africa and Malawi. Xpert+FujiLAM was cost-effective in both countries. Xpert+FujiLAM for all patients remained cost-effective compared with sequential testing and CD4-stratified testing strategies. FujiLAM use added 3.5% (South Africa) and 4.7% (Malawi) to 5-year healthcare costs of tested patients, primarily reflecting ongoing HIV treatment costs among survivors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>FujiLAM with Xpert for tuberculosis testing in hospitalized people with HIV is likely to increase life expectancy and be cost-effective at the currently anticipated price in South Africa and Malawi. Additional studies should evaluate FujiLAM in clinical practice settings.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciaa1698","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T20:12:30Z","timestamp":1605298350000},"page":"e2077-e2085","source":"Crossref","is-referenced-by-count":20,"title":["Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"73","author":[{"given":"Krishna P","family":"Reddy","sequence":"first","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M","family":"Denkinger","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Broger","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C","family":"McCann","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Gupta-Wright","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, University College London, London, United Kingdom"},{"name":"Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Malawi-Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Kerkhoff","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela P","family":"Pei","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma M","family":"Shebl","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L","family":"Fielding","sequence":"additional","affiliation":[{"name":"TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"School of Public Health, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P","family":"Nicol","sequence":"additional","affiliation":[{"name":"Infection and Immunity, University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Robert","family":"Horsburgh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA"},{"name":"Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cape Town, Cape Town, South Africa"},{"name":"Wellcome Center for Infectious Diseases Research in Africa and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A","family":"Freedberg","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts General Hospital, Massachusetts, USA"},{"name":"Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle P","family":"Walensky","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts General Hospital, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"2021100522531170800_CIT0001","author":"UNAIDS"},{"key":"2021100522531170800_CIT0002","doi-asserted-by":"crossref","first-page":"e1000296","DOI":"10.1371\/journal.pmed.1000296","article-title":"The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study","volume":"7","author":"Cohen","year":"2010","journal-title":"PLoS Med"},{"key":"2021100522531170800_CIT0003","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","article-title":"Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis","volume":"29","author":"Gupta","year":"2015","journal-title":"AIDS"},{"key":"2021100522531170800_CIT0004","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","article-title":"Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial","volume":"387","author":"Peter","year":"2016","journal-title":"Lancet"},{"key":"2021100522531170800_CIT0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","article-title":"Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial","volume":"392","author":"Gupta-Wright","year":"2018","journal-title":"Lancet"},{"key":"2021100522531170800_CIT0006","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1473-3099(19)30001-5","article-title":"Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study","volume":"19","author":"Broger","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021100522531170800_CIT0007","doi-asserted-by":"crossref","first-page":"1901259","DOI":"10.1183\/13993003.01259-2019","article-title":"Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV","volume":"55","author":"Kerkhoff","year":"2020","journal-title":"Eur Respir J"},{"key":"2021100522531170800_CIT0008","doi-asserted-by":"crossref","first-page":"ofz530","DOI":"10.1093\/ofid\/ofz530","article-title":"Diagnostic accuracy of a novel and rapid lipoarabinomannan test for diagnosing tuberculosis among people living with HIV","volume":"7","author":"Bjerrum","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2021100522531170800_CIT0009","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2214-109X(18)30436-4","article-title":"Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study","volume":"7","author":"Reddy","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2021100522531170800_CIT0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMsa1214720","article-title":"Cost-effectiveness of HIV treatment as prevention in serodiscordant couples","volume":"369","author":"Walensky","year":"2013","journal-title":"N Engl J Med"},{"key":"2021100522531170800_CIT0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1513\/AnnalsATS.201905-418OC","article-title":"Shortened tuberculosis treatment for people with HIV in South Africa: a model-based evaluation and cost-effectiveness analysis","volume":"17","author":"Reddy","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2021100522531170800_CIT0012","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12879-016-1837-z","article-title":"Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial","volume":"16","author":"Gupta-Wright","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2021100522531170800_CIT0013","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/oso\/9780195108248.003.0009","article-title":"Reporting cost-effectiveness studies and results","volume-title":"Cost-effectiveness in health and medicine","author":"Siegel","year":"1996"},{"key":"2021100522531170800_CIT0014","author":"Malawi Ministry of Health","year":"2016"},{"key":"2021100522531170800_CIT0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4102\/sajhivmed.v18i1.776","article-title":"Adult antiretroviral therapy guidelines 2017","volume":"18","author":"Meintjes","year":"2017","journal-title":"South Afr J HIV Med"},{"key":"2021100522531170800_CIT0016","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"2021100522531170800_CIT0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12916-017-0822-8","article-title":"Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort","volume":"15","author":"Lawn","year":"2017","journal-title":"BMC Med"},{"key":"2021100522531170800_CIT0018","first-page":"CD009593","article-title":"Xpert MTB\/RIF and Xpert MTB\/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults","volume":"6","author":"Horne","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021100522531170800_CIT0019","author":"National Health Laboratory Service"},{"key":"2021100522531170800_CIT0020","doi-asserted-by":"crossref","first-page":"e0192991","DOI":"10.1371\/journal.pone.0192991","article-title":"Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: a prospective hospital cohort study in Malawi","volume":"13","author":"Maheswaran","year":"2018","journal-title":"PLoS One"},{"key":"2021100522531170800_CIT0021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5588\/ijtld.12.0627","article-title":"Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults","volume":"17","author":"Sun","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2021100522531170800_CIT0022","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/infdis\/jiu821","article-title":"Defining the needs for next generation assays for tuberculosis","volume":"211(Suppl 2)","author":"Denkinger","year":"2015","journal-title":"J Infect Dis"},{"key":"2021100522531170800_CIT0023","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2021100522531170800_CIT0024","author":"World Health Organization","year":"2019"},{"key":"2021100522531170800_CIT0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijid.2018.08.005","article-title":"Incremental yield and cost of urine determine TB-LAM and sputum induction in seriously ill adults with HIV","volume":"75","author":"Boyles","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2021100522531170800_CIT0026","doi-asserted-by":"crossref","first-page":"e0170976","DOI":"10.1371\/journal.pone.0170976","article-title":"Incremental yield of including determine-TB LAM assay in diagnostic algorithms for hospitalized and ambulatory HIV-positive patients in Kenya","volume":"12","author":"Huerga","year":"2017","journal-title":"PLoS One"},{"key":"2021100522531170800_CIT0027","doi-asserted-by":"crossref","first-page":"20714","DOI":"10.7448\/IAS.19.1.20714","article-title":"TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis","volume":"19","author":"Ford","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"2021100522531170800_CIT0028","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1038\/s41598-017-09895-7","article-title":"Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays","volume":"7","author":"Kerkhoff","year":"2017","journal-title":"Sci Rep"},{"key":"2021100522531170800_CIT0029","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2471\/BLT.13.126532","article-title":"Drug resistance of Mycobacterium tuberculosis in Malawi: a cross-sectional survey","volume":"92","author":"Abouyannis","year":"2014","journal-title":"Bull World Health Organ"},{"key":"2021100522531170800_CIT0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAI.0000000000000970","article-title":"Empiric TB treatment of severely Ill patients with HIV and presumed pulmonary TB improves survival","volume":"72","author":"Katagira","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021100522531170800_CIT0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5588\/ijtld.12.0505","article-title":"Tuberculosis patients in primary care do not start treatment: what role do health system delays play?","volume":"17","author":"Claassens","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2021100522531170800_CIT0032","doi-asserted-by":"crossref","first-page":"e37634","DOI":"10.1371\/journal.pone.0037634","article-title":"Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients","volume":"7","author":"Pepper","year":"2012","journal-title":"PLoS One"},{"key":"2021100522531170800_CIT0033","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/QAD.0b013e3283390dd1","article-title":"Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy","volume":"24","author":"Lawn","year":"2010","journal-title":"AIDS"},{"key":"2021100522531170800_CIT0034","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/QAD.0b013e3283522d47","article-title":"The cost-effectiveness of routine tuberculosis screening with Xpert MTB\/RIF prior to initiation of antiretroviral therapy: a model-based analysis","volume":"26","author":"Andrews","year":"2012","journal-title":"AIDS"},{"key":"2021100522531170800_CIT0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.qai.0000225729.79610.b7","article-title":"CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment","volume":"42","author":"Holmes","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021100522531170800_CIT0036","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/135965350701200416","article-title":"The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in C\u00f4te d\u2019Ivoire","volume":"12","author":"Losina","year":"2007","journal-title":"Antivir Ther"},{"key":"2021100522531170800_CIT0037","doi-asserted-by":"crossref","first-page":"e54587","DOI":"10.1371\/journal.pone.0054587","article-title":"What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?","volume":"8","author":"Pooran","year":"2013","journal-title":"PLoS One"},{"key":"2021100522531170800_CIT0038","author":"Clinton Health Access Initiative"},{"key":"2021100522531170800_CIT0039","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"2021100522531170800_CIT0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0272989X9401400308","article-title":"Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment","volume":"14","author":"Cantor","year":"1994","journal-title":"Med Decis Making"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1698\/35373693\/ciaa1698.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e2077\/40511827\/ciaa1698.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e2077\/40511827\/ciaa1698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T11:26:31Z","timestamp":1723893991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/7\/e2077\/5983890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,11,17]]},"published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1698","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2020,11,17]]}}}